Clarivate
Depends
Confidence: Medium
Buy if you're an institution, pharma company, or IP firm needing curated citation, patent, or drug-pipeline data and can absorb enterprise contracts.
Comparison
Clarivate and InspireIP both land on Depends.
Buy if you're an institution, pharma company, or IP firm needing curated citation, patent, or drug-pipeline data and can absorb enterprise contracts.
Buy if you run a structured corporate innovation or IP program that needs disciplined invention disclosure; reviewers rate it 4.8/5 and pricing is not per-seat.
| Compare | Clarivate | InspireIP |
|---|---|---|
| Verdict | Depends | Depends |
| Best for | Universities and research libraries | Corporate innovation teams |
| Who it's not for | Individual researchers wanting quick citation lookups | Solo inventors filing one or two patents |
| Privacy | Mature program: Trust Center, HackerOne disclosure program, and advisories issued for third-party CVEs in its software.⁷ | No known public vulnerabilities found in the sources reviewed. |
| Support quality | Trustpilot 2.8 average | No support evidence in sources |
| Public sentiment | Sentiment splits: solid G2 product ratings but weak Trustpilot scores and lukewarm employee reviews.¹ | G2 reviewers (21 reviews, 4.8/5) consistently praise ease of use and the intuitive idea submission flow.14 |
| Biggest gotcha | Pricing is negotiated per product and seat; expect sales-led contracts, no self-serve checkout.10 | 30-day trial only, no permanent free tier; entry cost from $150 per TrustRadius |